CN1281287C - Therapeutic film forming composition and treatment system - Google Patents
Therapeutic film forming composition and treatment system Download PDFInfo
- Publication number
- CN1281287C CN1281287C CNB028035100A CN02803510A CN1281287C CN 1281287 C CN1281287 C CN 1281287C CN B028035100 A CNB028035100 A CN B028035100A CN 02803510 A CN02803510 A CN 02803510A CN 1281287 C CN1281287 C CN 1281287C
- Authority
- CN
- China
- Prior art keywords
- therapy system
- definition
- fingernail
- supporting element
- heat production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
- A61Q3/02—Nail coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
A film forming composition incorporating one or more therapeutic substances for application to nails and/or skin surfaces which can be employed independently or, if desired, in combination with an easily employed holding or support member for delivering heat directly to the application site for treating nails and/or skin surfaces for a wide variety of medical problems is disclosed. The disclosed treatment system for providing an effective transdermal delivery of therapeutic agents possesses broad applicability for a wide range of medical conditions, including the numerous diseases, disorders, and medical problems, all of which are capable of being treated using this treatment system. In particular, diseases, disorders, and medical conditions which include, but are not limited to, psoriasis, skin cancers, warts, leishmaniasis, mycobacteria, and granuloma annulare can be specifically treated under controlled conditions due to the efficacy of heat penetration in treating these disorders.
Description
Technical field
The present invention relates to fingernail, toenail the inside and disease following and that skin surface is found, relate more specifically to be used for rem is delivered to the fully-integrated therapy system of the disease that influences fingernail and skin surface.
Background technology
The skin surface that influence is individual and/or the disease right and wrong of fingernail and/or toenail are usually seen, and are often brought practical difficulty to diseased individuals.Describe in detail as this paper, found that a large amount of diseases torments individuality by this way, and fail to obtain actual effectively medicine.
In order to be familiar with the difficulty that runs in this field, it is important understanding the fingernail particular structure.Known fingernail is the cutin adnexa by the uniqueness of the stratum germinativum epithelium generation of basic unit.The similar of typical fingernail is in the structure of skin surface, and wherein the base table chrotoplast produces horny layer.But fingernail has the cutin harder than skin owing to having higher sulfenyl layer albumen.
Fingernail is not grown by adding from the cell of basic unit with stopping.The unitary epithelium component of fingernail comprises the proximal nail fold that is similar to skin or slight sour jujube skin shape, and comprises the granulosa with mitogen activation.The end products of cutin is an epidermis.Basic unit is sour jujube skin shape and does not contain the granulosa with minimum mitogen activation.The cutin end products is the deck.Nail matrix is very flat and do not contain the granulosa with minimum mitogen activation, and on the deck when far-end moves only the minority horn cell be added to below the deck.At last, nail matrix is sour jujube skin shape, contains the granulosa with mitogen activation, and similarly is only to have the minority horn cell to be added to the lower floor on far-end deck with epidermis.
Fingernail and disease of nail are being carried out may or running into a large amount of problems below the nail surface at fingernail itself in the therapeutic process.In order to fully understand the importance of this problem, provide following table may experience and need the effectively representative sample inventory of disease, disease and the medical problem of treatment as multiple:
Table A
Influence the dermatosis of fingernail
Psoriasis/pustular psoriasis
Lichen planus
The congenital atrophy of fingernail
The glossiness lichen
Lichen striatus
Struvite linear verrucous epidermal nevus
Alopecia areata
Twenty-nail dystrophy (coarse onychitis)
The eczema of involving fingernail
The Pornpholyx that involves fingernail
Parakeratosis pustulosa (Parakeratosis pustalosa)
Pemphigus
Bullous pemphigoid
Acquired bulla type epidermolysis
The erythema multiforme of involving fingernail
Darier's disease
Pityriasis rubra pilaris
Palmoplantar keratoderma
The Bazex syndrome
Table B
Fingernail in the general disease is got involved
Onycholysis as the 3rd common disease of nail in the dermatological after tinea unguium and wart.
Fingernail pigmentation (Chromonychia)
Hemorrhage
Piptonychia (onycholysis or spontaneous loss of finger-nail fully)
Hapalonychia (soft fingernail)
Onychorrhexis (old, old fingernail)
Coarse first
Table C
The fingernail tumor
The epidermis tumor
Optimum
Clavus under the fingernail
Wart
Cyst (epidermis inclusion/epidermoid cyst)
Onychomatricoma
Melanocytoma
Glomus tumor
Mucocele
Purulent granuloma
Pernicious
Bowen's disease/squamous cell carcinoma
Malignant melanoma
Cutaneous tumor
Optimum
Fibroma
Hemangioma
Glomus tumor
Purulent granuloma
Splinter hemorrhage
Tumor under the fingernail
Exostosis under the fingernail
Hematoma under the fingernail
The coloring disease
Hypopigmentation/increase disease/melanonychia
Infect
Fungal infection (dermatophytes, yeast, deep layer fungus)
Bacterial infection (Gram-positive, gram negative bacteria etc.)
Viral infection (herpes simplex, wart etc.)
Other infection (anonymous mycobacteria, sporotrichin, leishmaniasis etc.)
Mixed infection (paronychia)
Table D
CDK
Da-Huai disease
Pachyonychia congenita
Congenital onychodysplasia
Bulla type epidermolysis
Twenty-nail dystrophy
Pityriasis rubra pilaris
Lamellar ichthyosis
Epidermolytic hyperkeratosis
Porokeratosis
Palmoplantar keratoderma
The periodicity of fingernail comes off
Ectodermal dysplasia
Luo-Tang syndrome
Dyskeratosis congenita
Acrodermatitis enteropathica
The Goldtz syndrome
The Kid syndrome
Table E
Fingernail changes/with aging diseases associated
Change
Variable color
Profile/shape
Surface abnormalities
Thickness
The linear growth that reduces
Disease
Crisp fingernail
Onychodystrophy-exogen
Onychauxis
Onychoclasis (clavus under the fingernail)
Ingrowing nail (ingrown nail)
Onychogryphosis
Splinter hemorrhage
Hematoma under the fingernail
Nail infection
Finding to be proved to be an individual extremely difficult field that obtains effectively treatment is psoriasis, particularly relevant with fingernail or toenail psoriasis treatment.The U.S. has more than 6,400,000 psoriasis cases according to estimates, influences the common American population of about 2%-3%.According to national psoriasis foundation, annual diagnosis about 200,000 routine new cases, and to cause annual total outpatient's cost be $160 ten thousand-$320 ten thousand.And annual according to estimates psoriatic loses about 5,600 ten thousand hours work.
The psoriasis of fingernail is very common, and is finding among all patients of 50% at the most.As if than toenail susceptible to more, this brings additional problem to fingernail, changes because the patient more may complain the fingernail of being seen easily.The result is, the influence of psoriasis fingernail disease is on the health also to be psychological.
The psoriasic clinical symptoms of fingernail depends on the unitary anatomy of the fingernail that involves position.These defectives alter a great deal, and comprise one or more fingernails depression, variable color, thicken and onycholysis (separating) from nail matrix.The effect of onycholysis also may relate to the similarly basic fingernail of tinea unguium under structure.Other is common is changed to division, Beau lines (the generally horizontal wrinkle in deck that is caused by intermittent basic unit psoriasis), the splinter hemorrhage on deck malnutrition, rice scholar's line (the horizontal white line on deck), Muehrcke line (because horizontal white line that the abnormal vascular pattern in the visible nail matrix causes in the whole deck), deck and refers to subungual hyperkeratosis.
The purpose of treatment psoriasis fingernail disease is to improve the health relevant with onychodystrophy and psychological weak.Unfortunately, the treatment of using at present can not be cured the psoriasis fingernail.Though multiple trial and Therapeutic Method are arranged in the prior art at present, do not have specific, consistent, the effective treatment of treatment fingernail psoriasis.
Used several different methods, comprised in part, the disease location and whole body method, radiotherapy etc.But most of these prior art Therapeutic Method have actual risk and complication, comprise general toxicity, radiation infectious-related complication, skin atrophy on every side, pain etc.In addition, advised that nail varuish is used for many prior art preparations treats psoriasis to be applied to fingernail, and many other fingernail diseases.
But it is invalid that the nail varuish of these prior aries also proves in the solution of the disease of nail that they are intended to treat.The result is, constantly need have the therapy system of a kind of safe and effective fingernail and disease of nail for a long time, finds satisfied scheme before use easily, safety and the effective the present invention of cost.
Therefore, a basic purpose of the present invention provides a kind of people's of being used for therapy system, and this system can make things convenient for and easily be applied to any target surface of people, comprises nail surface and skin surface, provide the rapid draing thin film, and the combining target therapeutic agent is to handle multiple medical problem.
Another object of the present invention provides a kind of therapy system efficiently, it is characterized in that the feature of above detailed description, and it also uses thermal gradient sending with further enhancing therapeutic agent.
Another object of the present invention provides the effective therapy system of a kind of height, and this system has the feature of above detailed description, and can be easily and be used for the treatment of a large amount of medical symptoms effectively.
Another object of the present invention provides a kind of therapy system efficiently, and this system has the feature of above detailed description, and also cooperate in conjunction with the maintenance that makes up and supporting element or with film-forming composition and heat production element and use easily and use guaranteeing.
Other and more specific purpose are that part is conspicuous, and will appear at hereinafter part.
Detailed Description Of The Invention
By using the present invention, eliminate all obstacles and the defective found in prior art compositions, system, method and the step, and obtain a kind of part, effective therapy system of using, making things convenient for, satisfy the needs of consumers, be used for a lot of medical problems of fingernail and/or skin surface.Obtain a kind of therapy system among the present invention, this therapy system comprises the film-forming composition that is applied to the therapeutant of fingernail and/or skin surface in conjunction with one or more, it can use separately, perhaps is used in combination with easy-to-use support or the carrier element that is used for heat directly is delivered to application site if necessary.
Therapy system of the present invention has the broad applicability that is used for a large amount of medical symptoms.Particularly, use the present invention can treat multiple disease, disease and the medical problem of above detailed description.Particularly, because effectiveness of the present invention and in use treatment in these diseases thermal break-through effectiveness and disease, disease, the medical symptom that can specifically treat or improve include but not limited to psoriasis, skin carcinoma, wart, leishmaniasis, mycobacterial diseases and granuloma annulare.
In this respect, the application of determining heat slows down, suppresses or reverses metabolic process, immunologic process or biological symptom or rely on process hot or that be influenced by heat.The result is, according to the embodiment of the present invention that comprise integrated therapy system, by being used in combination the treatment that this paper describes in detail with thermal source or containing the medicine film-forming composition and treat multiple medical symptom effectively.
Found that the use of heat produces positive, collaborative effect to the targeting of the medicine of predetermined quantity and/or penetration enhancers, controlled sending.In this respect, the application of the invention improvement or effective treatment are used for above disease of nail, disease and medical symptom and/or the medicine of skin and subcutaneous surface and/or the topical application of penetration enhancers that intactly describes in detail.And, medicine and/or penetration enhancers are delivered to fingernail, or by fingernail be delivered to basic organization with realize need not be oral and/or need not be parenteral, system, transdermal delivery, this method itself is effectively and further to be enhanced in the presence of controlled thermal gradient.
Usually, it is relevant with the basic organization of being correlated with fingernail therapy system of the present invention and fingernail below to be described in detail in detail.But, the present invention be equally applicable to find at skin surface with the incoherent disease of fingernail, disease and medical problem.Therefore, should be appreciated that the present invention and content provided herein are equally applicable to use at any skin surface.Therefore, being provided at using in detail and using on the fingernail only is the purpose that exemplifies, and in fact the invention is intended to be included in application and use on fingernail and the skin surface.
A solvent of the present invention is a kind of film-forming composition that is used for one or more therapeutants are delivered to its application site of formulated.This film-forming composition can be used for anyone surface, but it is used in particular for fingernail to treat any target disease of nail.
Except comprising one or more therapeutants, film-forming composition of the present invention also preferably comprises film former, plasticizer and carbamide, and all these is in the volatile vehicle.With reference to table 1, the dosage range of every kind of composition is very clearly.This table provides total usable range and preferable range.
Table I
Composition | Total size (%w/v) | Preferable range (%w/v) |
Film former | 0.5-25 | 5-10 |
Plasticizer | 0.5-25 | 1-5 |
Carbamide | 0.5-20 | 1-6 |
Therapeutant | Required effective dose | Required effective dose |
Solvent/volatile vehicle | 40-90 | 50-80 |
In preparation of compositions of the present invention, can use any required film former.But, in preferred compositions, film former comprises at least a following material that is selected from: polyvinyl acetate, vinyl acetate and acrylic acid polymerization of mixtures thing, the mixed polymer of (methyl) acrylic acid and (methyl) acrylate, polyvinyl acetate, the polyethylene butyryl, polyvinyl alcohol, cellulose derivative such as acetic acid gather the O-phthalic acid cellulose, cellulose acetate-butyrate, cellulose-acetate propionate, celluloid, sulfate cellulose, ethyl cellulose and cellulose acetate. in this respect, a kind of preferred film former is aminomethyl acrylate copolymer (II), this material is by Rohm Pharma GmbH, Weiterstadt, Germany sells, and trade mark is called " Eudragit RL-100 ".
In addition, can in objective composition, use any target plasticizer, in a preferred composition, this plasticizer composition comprises at least a following material that is selected from: glyceryl triacetate, polyhydric alcohol such as propylene glycol and butanediol, Oleum Ricini, Camphora and phthalic acid ester.In this respect, preferred plasticizer comprises dibutyl phthalate, and this material is sold by Eastman Chemicals, and trade mark is called " Eastman DBT Plasticizer ".
In preparation of compositions of the present invention, can use any The suitable solvent or volatile vehicle.But, found that solvent/volatile vehicle preferably comprises one or more and is selected from following material: alcohol (as ethanol), ketone (as acetone), ether (as chloroform), aromatic hydrocarbons (as toluene), ester (as ethyl acetate) and water.
In the combination of selecting and preparing the composition that is used for solvent/volatile vehicle, found that preferred chemical compound or chemical compound should be as the solvents of carrier, and have such evaporation rate: slowly to being enough to that active component is applied to fingernail or skin surface fully, and soon to preventing that wiping falls under the situation that compositions comes in contact on fingernail or skin surface and another surface.
The preferred prescription such as the Table II that are used for this treatment film-forming composition describe in detail.In the preparation of this preferred compositions, at first with film former, promptly Eudragit RL-100 is dissolved in acetone/water carrier.After forming settled solution, add other composition and be mixed to dissolving fully mutually with it.In addition, also add goal treatment agent and the mutual goal treatment film-forming composition that is applied to fingernail or skin with formation that mixes.
Table II
Composition | Quantity |
Clobetasol propionate | 0.05%w/v |
Carbamide | 3%w/v |
Dibutyl phthalate | 1.5%w/v |
Eudragit RL-100 | 7%w/v |
Ethanol | 70%w/v |
Water | In right amount to 100% |
In the finishing of treatment film-forming composition of the present invention, will be enough to provide one or more therapeutants of the quantity of interacting goals to be added to said composition.Usually, the therapeutant of use comprises that one or more are selected from following material: corticosteroid, chemotherapeutant, anesthetis, hydryllin, antibacterial, antiparasitic, antiviral agent, antioxidant, tar, dithranol, immunomodulator, keratolytic and antitumor agent.Though a large amount of chemical products is within the scope of these medicines, following inventory provides the exemplary composition that effectiveness is made the part of therapy system of the present invention.But, provide this inventory only to be used to the purpose that exemplifies, and be not intended to restriction the present invention.
In this respect, corticosteroid can comprise that one or more are selected from following material: hydrocortisone, triamcinolone, betamethasone and any other steroid commonly used in the topical application of skin; Chemotherapeutant can comprise that one or more are selected from following material: 5FU, bleomycin, methotrexate, cytotoxicity medicine; Anesthetis can comprise that one or more are selected from following material: lignocaine, prilocaine and Pramoxine; Hydryllin can comprise that one or more are selected from the material of diphenhydramine and salt or doxepin; Antibacterial can comprise that one or more are selected from following material: gentamycin, tetracycline, erythromycin and Clindamicin, amoxicillin; Antiparasitic can comprise that one or more are selected from following material: metronidazole, Permethrin and crotamiton; Antiviral agent can comprise that one or more are selected from the material of acycloguanosine; Antioxidant can comprise that one or more are selected from the material of ascorbic acid and tocopherol; Immunomodulator can comprise that one or more are selected from the material of imiquimod and beta glucan; Keratolytic can comprise that one or more are selected from salicylic material; And antitumor agent can comprise that one or more are selected from the material of cytotoxicity medicine and immunomodulator.
And, describe in detail as this paper, found that the use of the thermal gradient that provided by a selectable embodiment of the present invention makes reinforcing agent more effectively use effectively.In this respect, as following abundant detailed description, the reinforcing agent of specifically benefiting from this embodiment of the present invention comprises that one or more are selected from following material: solvent, surfactant, ether, ester, fatty glyceride, carbamide, oleate, liposome, biostearin and closing compound.
As discussed above, the present invention includes the treatment film-forming composition is used separately in one embodiment, also comprise and use the hot delivery elements that is used in combination with the treatment film-forming composition.Use when of the present invention at fingernail and/or skin surface, will treat film-forming composition and be applied to fingernail and/or skin surface.When using this embodiment, in case form thin layer, hot delivery elements is placed on the fingernail so that the direct successive thermal gradient that influences fingernail and/or skin surface to be provided.
As above-mentioned, found that the application of heat strengthens sending and rendeing a service of many therapeutants.When using this embodiment, preferably send by using the heat that makes up with holding element to send liner realization heat.In preferred construction, heat release liner or hot delivery patch are as thermal source.Heat release liner or hot delivery patch be developed in the past and generally comprised contain in the presence of oxygen, will take place exothermic reaction with produce heat chemical substance porous membrane or spin cloth or the liner of nonwoven cloth material.
Though can use any desired chemical substance, heat release liner or hot delivery patch generally comprise the mixture of moxa or iron powder, activated carbon, the wood fiber, water and salt.Selectively, the mixture that uses alkaline sulfides and cementite and chemical substance and storage contact with oxygen before the use preventing.In addition, the big or small sufficient to guarantee of spacer holes is realized target air flow.If necessary, can use any heat production liner, product or structure.
Using tiles/mats to be enclosed in as last does not have in the pouch smell and to form in noble gas such as nitrogen.As long as tiles/mats remains in the hermetic container before use, just chemical reaction can not take place.But, in case this pouch is opened the then exothermic reaction that the existence of oxygen causes chemical reaction and takes place to expect in the air.
In embodiments of the invention, by allowing user that liner or patch are used heat release liner or hot delivery patch individually at thermal therapeutical targeting desired area.If necessary, by relevant bonder hot delivery patch or heat release liner are remained on target site separately safely.
In case liner/paster safety remain on accurate target location, the holding element of therapy system of the present invention is fixed on the target location, make add heating pad or heat release paster periphery around or remain on the target location safely, help to regulate and control heat level and the air that arrives heat release liner or hot delivery patch transmit.By this method, that realize ideal, controlled heat is sent or thermal gradient, can treat a large amount of medical symptoms effectively.Except the controlled thermal that is provided for directly treating some medical symptom is sent, it is effectively that the thermal gradient that provides in the embodiment of fully-integrated therapy system of the present invention is provided, and improves the penetrance of bonded whole body and topical medications in the treatment film-forming composition.
Can obviously find out from above-mentioned, use therapy system of the present invention to treat a large amount of multiclass medical symptoms effectively and effectively.As described in detail above, this has an embodiment of therapy system to introduce hot delivery patch or the heat release liner that makes up with holding element, and this holding element is with hot delivery patch or the heat release liner remains on the specific medical problem of appearance and expectation heat is sent or the accurate target position of thermal gradient.In addition, fingernail or skin penetration reinforcing agent can be integrated into therapy system of the present invention with its effectiveness of further enhancing.
Field by the application heat that lot of documents is put down in writing is the treatment of wart.In this respect, 5,053,024 full disclosure of Dvoretzkv United States Patent (USP) the thermal therapeutical of wart.But it generally is unknown using heat and use heat for the transmission that helps medicine and fingernail/skin penetration reinforcing agent and absorption in other skin disorder or medical problem, and represents the progress in present technique field, especially with the combination for the treatment of film-forming composition.
This embodiment of the application of the invention therapy system, comprise treatment film-forming composition with holding element and hot delivery patch or the combination of heat release liner, the temperature of fingernail or skin raises or remains on about 39-45 ℃, and the time range that continues is about 1-10 hour; The application of the invention, the heat level of fingernail or contact skin remains on little and controlled scope, and this representative is used for the treatment of the optimal heat contact of medical symptom and accurately sends drug target.The result realizes best performance and treatment.
According to the present invention, the supporting element specific design is used for fast and easily being installed in the part of human body as finger, with the fingernail peripheral ring of treatment around in conjunction with and the connection and remain on accurate destination locations of cooperate with film-forming composition and hot delivery patch or heat release liner.And, supporting element of the present invention is also specifically constructed by the material that is designed for especially with hot delivery patch or the cooperation of heat release liner especially, so that its cooperative interaction, thereby guarantee to keep accurate temperature required level and in the object time of smart phase, realize best oxygen flow.
The structure construction of can plurality of optional selecting forms the supporting element of maintenance of the present invention system, to provide desirable, to be directly installed on any finger or toe fast, easily, safely, maybe may need any human body anatomic part for the treatment of.In this respect, an embodiment of maintenance of the present invention system comprise one continuously, columniform tube elements basically.
By using cylindrical elements, maintenance of the present invention system can easily be installed on user's the hands or foot, and peripheral ring is around in fingernail to be treated, keeps safely, and cooperates with the heat release liner or the hot delivery patch of the pre-installation that is in the precision target position.
Feature of the present invention is the material that is used to form therapy system of the present invention.In this respect, most weaving and non-woven material can be used in the formation holding element.
But, found that preferable material comprises complete elastomer or the elastomer that wherein forms, easy installation to be provided and the maintainer line blanket insurance to be held in the pliability of appropriate location.In a preferred construction, this elastomer integral body is formed the part of this material, as thermoplastic elastomer (TPE).In this respect, preferred thermoplastic comprises and is selected from following foamed thermoplastic elastomer: polyurethane, polyolefin, polybutene, polyethylene, polyester, ethylene-propylene rubber, polypropylene, silicone and based on the resin of vinyl.
By using foamed thermoplastic elastomer, obtain the accurate target combination of closed cell and open cell, wherein the ratio of closed cell and open cell is controlled in the preferred range.By this method accurately the hot retentivity of control material and/or insulating properties and make material will from around, oxygen in the surrounding air is directly delivered to the position of hot delivery patch or heat release liner.
According to embodiment of the present invention of using heat to send, the insulation that the temperature that directly is delivered to fingernail or skin by heat release liner or hot delivery patch is provided by this maintenance system and accurately in the preset time length inner control in narrow scope.In addition, oxygen cycles through the maintenance system continuously so that the proper operation of heat release liner/paster to be provided, and air circulation is offered the surface of the fingernail or the skin of treatment.
Must see purpose that effective realization is above-mentioned and other purpose of obviously finding out by above description,, in described product and in described structure, do some modification and do not deviate from scope of the present invention because can state on the implementation in the process of method.The application is intended to the implication that will should be interpreted as exemplifying at all contained themes of above-mentioned description and not limit.
Will also be understood that following claim is intended to cover general and specific feature of the present invention as herein described, and all statements as the protection domain of the present invention of language content should drop on wherein.
Be appreciated that especially under the situation that its implication allows, in this claim, the compatible blend that is intended to comprise these compositions with the composition or the chemical compound of odd number citation.
After describing our invention, what we will look for novelty with expectation by the content that patent guarantees is:
Claims (15)
1. one kind is used for the effective transdermal delivery the pure man of therapeutic agent to treat the therapy system of a large amount of medical symptoms, and this system comprises:
A. film-forming composition, said composition comprises:
1). weight/volume accounts for the film former of 0.5%-25% of the weight/volume of whole compositions greatly;
2). weight/volume accounts for the plasticizer of 0.5%-25% of the weight/volume of whole compositions greatly;
3). weight/volume accounts for the carbamide of 0.5%-20% of the weight/volume of whole compositions greatly;
4). weight/volume accounts for the solvent/volatile vehicle of 40%-90% of the weight/volume of whole compositions greatly; With
5). at least a therapeutant of effective dose, it is selected from following material: corticosteroid, chemotherapeutant, anesthetis, hydryllin, anti-infective, antifungal, antibacterial, antiparasitic, antiviral agent, antioxidant, tar, dithranol, immunomodulator, keratolytic and antitumor agent;
B. heat production liner, this heat production liner in conjunction with wherein comprise and be fabricated and be used for sending when the activation heat production device of the heat of target level; With
C. one kind keeps and supporting element, and this element is fabricated and is used for
1). cooperate with the heat production liner and heat can be directly applied to the intended application position of film-forming composition; With
2). remain on the part of human body surface safely, engage with hot delivery patch/liner and film-forming composition cover type;
Realize a kind of any target part that can remain on human body safely thus, thereby the therapy system of therapeutic agent and heat is provided for any target site in the mode of accurate control.
2. the therapy system of claim 1 definition, wherein supporting element is fabricated to be used for being installed to safely and is selected from a following human body parts: finger, arm, elbow, toe, foot, lower limb, wrist, ankle and upper torso.
3. the therapy system of claim 1 definition, wherein this maintenance and supporting element comprise one make elongation that this element remains on any target location safely, planar structure in conjunction with fixture basically.
4. the therapy system of claim 3 definition, wherein this fixture is defined as and comprises a kind of material that is selected from binding agent and hook and annular holder.
5. the therapy system of claim 1 definition, wherein this maintenance and supporting element also are defined as by thermoplastic elastic material and form.
6. the therapy system of claim 5 definition, wherein this thermoplastic elastic material is defined as and comprises a kind of following material that is selected from: polyurethane, polyolefin, polybutene, polyethylene, polyester, ethylene propylene rubber, polypropylene, silicone and vinylite.
7. the therapy system of claim 4 definition, wherein this fixture is defined as and comprises at least two and be fixed on the apparent surface of this maintenances and supporting element and be positioned at the appropriate location that matches each other, cooperate, be bonded with each other will keep and supporting element remains on any target location of individuality or cooperation, the blocking element at position safely.
8. the therapy system of claim 7 definition, wherein this cooperation, blocking element comprise hook and annular fixture to also being defined as, wherein this first pair of blocking element be installed in keep and the first surface of supporting element and with the heat production liner interval of wherein installing, the connection of cooperating; And second interlocking hook and the annular retaining element is fixed on the reverse side of whole basically maintenance and supporting element safely, and what any actually thus target area and position obtained quickly and easily that cooperation, the locking of this first and second blocking element install is bonded with each other.
9. the therapy system of claim 4 definition, wherein this erecting device also is defined as and comprises and the heat production liner connects adhesive phase with a surface that is fixed on this maintenance and supporting element of realizing fixture, thereby safely maintenance and supporting element and heat production liner is fixed on any target location or the position of individual's skin.
10. the therapy system of claim 4 definition, wherein this heat production liner also is defined as by contacting with oxygen and activates, and this therapy system also be defined as be packaged in oxygen-free, peripheral around releasable container in, to use by this delivery system is stored in make single heat production liner can make short-term in the releasable container when not using recyclingly.
11. the therapy system of claim 1 definition, wherein this film former also is defined as and comprises a kind of following material that is selected from: the mixed polymer of polyvinyl acetate, vinyl acetate and acrylic acid mixed polymer, acrylic acid and acrylate, polyvinyl acetate, polyethylene butyryl, polyvinyl alcohol, cellulose derivative, the poly-O-phthalic acid cellulose of acetic acid, cellulose acetate-butyrate, cellulose-acetate propionate, celluloid, sulfate cellulose, ethyl cellulose and cellulose acetate.
12. the therapy system of claim 11 definition, wherein this plasticizer also is defined as and comprises at least a following material that is selected from: glyceryl triacetate, polyhydric alcohol, propylene glycol, butanediol, Oleum Ricini, Camphora and phthalic acid ester.
13. the therapy system of claim 12, wherein this solvent/volatile vehicle comprises at least a following material that is selected from: alcohol, ethanol, ketone, acetone ether, chloroform, aromatic hydrocarbons, toluene, ester, ethyl acetate and water.
14. the therapy system of claim 1 definition, wherein this film-forming composition also includes the reinforcing agent that helps the delivery treatments material.
15. the therapy system of claim 14 definition, wherein this reinforcing agent comprises one or more and is selected from following material: solvent, surfactant, ether, ester, fatty glyceride, carbamide, oleate, liposome, biostearin and closing compound.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26043001P | 2001-01-09 | 2001-01-09 | |
US60/260,430 | 2001-01-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1514706A CN1514706A (en) | 2004-07-21 |
CN1281287C true CN1281287C (en) | 2006-10-25 |
Family
ID=22989129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028035100A Expired - Fee Related CN1281287C (en) | 2001-01-09 | 2002-01-07 | Therapeutic film forming composition and treatment system |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1357873A4 (en) |
JP (1) | JP2004520337A (en) |
KR (1) | KR20030072592A (en) |
CN (1) | CN1281287C (en) |
AU (1) | AU2002248308B2 (en) |
BR (1) | BR0206307A (en) |
CA (1) | CA2431236A1 (en) |
HU (1) | HUP0501023A3 (en) |
IL (1) | IL156458A0 (en) |
NO (1) | NO20033123L (en) |
NZ (1) | NZ526806A (en) |
PL (1) | PL362920A1 (en) |
WO (1) | WO2002055023A2 (en) |
ZA (1) | ZA200305125B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8741333B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US8741332B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for dermally treating neuropathic pain |
JP4863437B2 (en) * | 2005-07-07 | 2012-01-25 | 有限会社日本健康科学研究センター | Bath film formulation |
WO2007070643A2 (en) * | 2005-12-14 | 2007-06-21 | Zars, Inc. | Compositions and methods for treating dermatological conditions |
JP5137175B2 (en) * | 2006-10-24 | 2013-02-06 | 有限会社日本健康科学研究センター | Film guard formulation |
EP1958613A1 (en) * | 2007-02-15 | 2008-08-20 | Polichem S.A. | Dermal film-forming liquid formulations for drug release to skin |
FR2937250B1 (en) * | 2008-10-21 | 2013-05-10 | Fabre Pierre Dermo Cosmetique | UREA-BASED FILMOGENOUS SOLUTION FOR THE TREATMENT OF NAIL PSORASIS |
US8771656B2 (en) * | 2011-12-14 | 2014-07-08 | Avon Products, Inc | Long-lasting easy wash-off cosmetic compositions |
CN104661655A (en) * | 2012-07-23 | 2015-05-27 | 陶氏环球技术有限责任公司 | Film composition for hard capsule shells |
PL2705847T3 (en) * | 2012-09-05 | 2015-02-27 | Psoriasis Creams Sweden Ab | Composition for treating psoriasis |
BR112016016841B1 (en) * | 2014-01-20 | 2022-09-06 | Boehringer Ingelheim Animal Health USA Inc. | TOPIC ADMINISTRATION FORMULATION |
CN104771781A (en) * | 2014-08-20 | 2015-07-15 | 江阴市柏御天谷生物医药有限公司 | Liquid wound protection film and preparation method thereof |
CN105999393A (en) * | 2016-07-15 | 2016-10-12 | 蓝佳堂生物医药(福建)有限公司 | Liquid band-aid and preparation method thereof |
CN107320766A (en) * | 2016-12-08 | 2017-11-07 | 沈阳圣劳伦斯医疗器械有限公司 | A kind of composition for skin superficial protecting wound surface |
CN108785739A (en) * | 2018-08-13 | 2018-11-13 | 中国人民解放军南京军区福州总医院 | A kind of full-service fluid adhesive bandage and preparation method thereof |
CN110859989B (en) * | 2019-10-25 | 2021-06-22 | 天津冠勤医药科技有限公司 | Liquid band-aid and preparation method thereof |
CN111166932B (en) * | 2020-02-29 | 2021-01-26 | 海南妙音春制药有限公司 | Liquid wound spray dressing and preparation method thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3612305A1 (en) * | 1986-04-11 | 1987-10-22 | Roehm Pharma Gmbh | LIQUID MEDICINE FOR THERAPY OF PSORIASIS BASED ON FILM-FORMING POLYMERS |
DE4212105A1 (en) * | 1992-04-10 | 1993-10-14 | Roehm Pharma Gmbh | Nail polish for the treatment of onychomycoses |
US5534021A (en) * | 1994-09-01 | 1996-07-09 | Dvoretzky; Israel | Heating pad for providing heat therapy |
JP4547046B2 (en) * | 1995-06-29 | 2010-09-22 | ワイス・エルエルシー | Heat cell |
RO118174B1 (en) * | 1997-08-21 | 2003-03-28 | Aventis Pharma Deutschland Gmbh | Nail polish and use thereof |
-
2002
- 2002-01-07 PL PL02362920A patent/PL362920A1/en unknown
- 2002-01-07 CN CNB028035100A patent/CN1281287C/en not_active Expired - Fee Related
- 2002-01-07 EP EP02717290A patent/EP1357873A4/en not_active Withdrawn
- 2002-01-07 NZ NZ526806A patent/NZ526806A/en unknown
- 2002-01-07 AU AU2002248308A patent/AU2002248308B2/en not_active Ceased
- 2002-01-07 KR KR10-2003-7009178A patent/KR20030072592A/en not_active Application Discontinuation
- 2002-01-07 IL IL15645802A patent/IL156458A0/en not_active IP Right Cessation
- 2002-01-07 HU HU0501023A patent/HUP0501023A3/en unknown
- 2002-01-07 WO PCT/US2002/000282 patent/WO2002055023A2/en active Application Filing
- 2002-01-07 BR BR0206307-7A patent/BR0206307A/en not_active IP Right Cessation
- 2002-01-07 CA CA002431236A patent/CA2431236A1/en not_active Abandoned
- 2002-01-07 JP JP2002555760A patent/JP2004520337A/en active Pending
-
2003
- 2003-07-01 ZA ZA200305125A patent/ZA200305125B/en unknown
- 2003-07-08 NO NO20033123A patent/NO20033123L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1357873A2 (en) | 2003-11-05 |
JP2004520337A (en) | 2004-07-08 |
BR0206307A (en) | 2004-07-20 |
KR20030072592A (en) | 2003-09-15 |
CA2431236A1 (en) | 2002-07-18 |
NO20033123L (en) | 2003-09-03 |
IL156458A0 (en) | 2004-01-04 |
WO2002055023A3 (en) | 2002-11-07 |
ZA200305125B (en) | 2004-10-01 |
AU2002248308B2 (en) | 2006-12-07 |
WO2002055023A2 (en) | 2002-07-18 |
NO20033123D0 (en) | 2003-07-08 |
CN1514706A (en) | 2004-07-21 |
NZ526806A (en) | 2006-03-31 |
HUP0501023A2 (en) | 2007-02-28 |
HUP0501023A3 (en) | 2008-04-28 |
EP1357873A4 (en) | 2009-09-09 |
PL362920A1 (en) | 2004-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1281287C (en) | Therapeutic film forming composition and treatment system | |
US20220015952A1 (en) | Adhesive support devices and methods of making and using them | |
RU2349315C9 (en) | Therapeutical plaster with polysiloxane matrix containing capsaicin | |
CN101056611A (en) | Gilsonite derived pharmaceutical delivery compositions and methods : cosmetic and nail applications | |
US20150196515A1 (en) | Multi-Layer Drug Delivery System | |
CN101032474A (en) | Rasagiline transparent patch for curing and preventing neurological diseases and the preparing method thereof | |
CN1231592A (en) | Fatty acid esters of glycolic and its salts as permeation enhancers | |
CN1747724A (en) | Transdermal granisetron | |
CN1531430A (en) | Local used composition containing antifungal agent | |
CN1846792A (en) | Transdermal plaster | |
US20080102108A1 (en) | Therapeutic film forming composition and treatment system therefor | |
RU2000123787A (en) | SUBSTITUTED 2-PHENYL-1- (3,4-DIHYDROXI-5-NITROPHENYL) HEADRAILOPAHEADOUSOUSOUSOXY-THERMAL CLEANING SYSTEMS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM AND PHARMACEUTICAL HEATING SYSTEM AND PHARMACEUTICAL SYSTEMS AND PHARMACEUTICAL SYSTEMS | |
KR20100126830A (en) | Transdermally absorbable preparation | |
AU2002248308A1 (en) | Therapeutic film forming composition and treatment system | |
CN1364078A (en) | Stretchable patch | |
CN1705482A (en) | Transdermal patch for external use comprising fentanyl | |
CN1154484C (en) | Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage | |
AU2018399215A1 (en) | Liquid dosage form for topical application | |
CN103990230B (en) | A kind of far-infrared magnet therapeutic healing accelerating dressing and preparation method thereof | |
CN1151866A (en) | External therapeutic composition for dermatitis | |
CN1579373A (en) | Transparent disappearing external administration carrier | |
CN101080219A (en) | External patches containing etofenamate | |
CN1195503C (en) | Transdermal patch and topical compositions comprising propylnorapomorphine | |
IE912577A1 (en) | Self-sticking matrix system for the sustained transcutaneous¹release of piribedil | |
CN1480128A (en) | Preparation of transparent, cryptomorphic external remedy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |